Online inquiry

IVTScrip™ mRNA-Human ANKRD17, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17903MR)

This product GTTS-WK17903MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD17 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001286771.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 26057
UniProt ID O75179
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD17, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK17903MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK27445MR IVTScrip™ mRNA-Human ARL5B, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARL5B
GTTS-WK16160MR IVTScrip™ mRNA-Human ANXA2R, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANXA2R
GTTS-WK16132MR IVTScrip™ mRNA-Human ANKRD6, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD6
GTTS-WK7739MR IVTScrip™ mRNA-Human ADGRE5, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADGRE5
GTTS-WK26295MR IVTScrip™ mRNA-Human ASB13, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ASB13
GTTS-WK26787MR IVTScrip™ mRNA-Human ARHGAP21, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP21
GTTS-WK22005MR IVTScrip™ mRNA-Human ARHGDIB, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGDIB
GTTS-WK20929MR IVTScrip™ mRNA-Human ANKRD49, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKRD49
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW